BostonGene Corporation: BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
Kort samengevat
AI-powered platform to predict patient safety and efficacy profiles, unlocking precision-driven oncology development BostonGene, the developer of the leading AI foundation model for tumor and immune
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij FinanzNachrichten.de.
Lees het volledige bericht ↗